Quarterly European Venture Capital report
17 July 2018
Q2 2018
1.
Europe & Israel venture capital
2.
Investment by country
3.
Investment by category
4.
Update on unicorns and big exits
Contents
2
3.1B 3.1B
3.4B
2.7B
4.1B
3.3B
3.2B 3.2B
3.9B
4.8B
5.0B
4.5B
4.8B
5.5B
3.8B 3.8B
4.7B
3.7B
5.0B
4.7B
4.0B 4.1B
4.6B
5.9B
7.2B
5.9B 5.9B
6.9B
1.5B
3.0B
4.5B
6.0B
7.5B
Q1
Q2
Q3
Q4
Q1
Q2
Q3
Q4
Q1
Q2
Q3
Q4
Q1
Q2
2015
2016
2017
2018
Europe
Biotech
Israel
All-time investment record of 5.5 billion excl. biotech
(including biotech and Israel 6.9 billion)
Source: Dealroom.co. Includes Israel. Excludes buyouts, secondary transactions, debt, ICOs, lending capital, grants.
1. Rounds below $2M are often reported with a delay of several months. Therefore, only rounds above $2M are shown here for better like-for-like comparison.
Investment in European & Israeli rounds VC rounds
3
838
283
453
250
500
750
1,000
1,250
Q1
Q2
Q3
Q4
Q1
Q2
Q3
Q4
Q1
Q2
Q3
Q4
Q1
Q2
2015
2016
2017
2018
Total
0-2M
2M+
Investment in European & Israeli rounds VC rounds
Decline in number of rounds is mostly
temporary, as rounds below 2 million are
announced with delays.
New investment record of 5.5 billion
(excl. Israel and biotech)
Our corporate clients typically want to see data incl.
biotech & Israel while our VC clients typically prefer to
see data Israel and biotech separately
786
1,618
833
200
400
600
800
1,000
1,200
1,400
1,600
1,800
Jan Feb Mar Apr May Jun
Jul Aug Sep Oct Nov Dec
2017
2018
10B
24B
13B
5B
10B
15B
20B
25B
Jan Feb Mar Apr May Jun
Jul Aug Sep Oct Nov Dec
2017
2018
As a result, investment activity to date in 2018 is well
ahead of 2017 (which was a record year itself)
Source: Dealroom.co. Includes Israel. Excludes buyouts, secondary transactions, debt, ICOs, lending capital, grants.
1. Rounds below $2M are often reported with a delay of several months. Therefore, only rounds above $2M are shown